back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-24 13:08 Tx date 2025-11-18 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,666 vol |
27,097 | |
| Filed 2025-11-24 13:08 Tx date 2025-11-24 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,169
+719 vol $8.58 each |
5,352 | |
| Filed 2025-11-12 11:30 Tx date 2025-09-08 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,667 vol |
28,763 | |
| Filed 2025-11-12 11:29 Tx date 2025-09-08 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,256
+756 vol $5.63 each |
4,633 | |
| Filed 2025-11-12 11:25 Tx date 2024-09-08 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
57 - Exercise of rights
|
-1,667 vol |
13,333 | |
| Filed 2025-11-12 11:24 Tx date 2024-09-08 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,098
+727 vol $11.14 each |
3,877 | |
| Filed 2025-06-25 11:00 Tx date 2025-06-24 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+12,097 vol |
32,097 | |
| Filed 2024-11-28 12:09 Tx date 2024-11-18 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,000 vol |
20,000 | |
| Filed 2024-11-28 12:09 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,000 vol |
15,000 | |
| Filed 2024-11-28 12:08 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2024-11-28 12:08 Tx date 2020-11-30 |
$PRN
Profound Medical Corp. |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-20 15:15 Tx date 2022-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,955
+1,735 vol $8.62 each |
3,150 | |
| Filed 2021-09-08 09:38 Tx date 2021-09-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,004
+535 vol $18.70 each |
1,415 | |
| Filed 2021-08-13 16:03 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119.97
+31 vol $3.87 each |
163 | |
| Filed 2021-08-13 15:59 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
-31 vol |
0 | |
| Filed 2021-08-13 15:49 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-158.67
-41 vol $3.87 each |
31 | |
| Filed 2021-07-13 10:52 Tx date 2021-07-01 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-158.67
-41 vol $3.87 each |
||
| Filed 2021-07-13 10:52 Tx date 2021-07-01 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-158.67
-41 vol $3.87 each |
31 | |
| Filed 2021-06-23 14:06 Tx date 2021-06-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,020
+880 vol $22.75 each |
880 | |
| Filed 2021-06-23 14:03 Tx date 2020-11-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|